Preliminary report on survival outcomes of BRCA mutation carriers with triple-negative breast cancer

被引：0
|
作者：
Aranda-Gutierrez, A. [1 ]
Ferrigno, A. S. [1 ]
Weitzel, J. N. [2 ]
Moncada-Madrazo, M. [1 ]
Gomez-Picos, A. [1 ]
Castillo-Orozco, A. [3 ]
Magallanes-Garza, G. I. [4 ]
Ortiz-Lopez, R. [4 ]
Villarreal-Garza, C. [1 ]
Aguilar, D. [4 ]
机构：
[1] Tecnol Monterrey, Hosp Zambrano Hellion, Breast Canc Ctr, San Pedro Garza Garcia, Mexico
[2] City Hope Natl Med Ctr, Div Clin Canc Genom, Duarte, CA USA
[3] McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ, Canada
[4] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Mexico
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.062
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
253P
引用
收藏
页码：S341 / S341
页数：1
相关论文
共 50 条
  • [21] BRCA2 Mutations and Triple-Negative Breast Cancer
    Meyer, Peter
    Landgraf, Katharina
    Hoegel, Bernhard
    Eiermann, Wolfgang
    Ataseven, Beyhan
    PLOS ONE, 2012, 7 (05):
  • [22] Frequency of Triple-Negative Breast Cancer in BRCA1 Mutation Carriers: Comparison Between Common Ashkenazi Jewish and Other Mutations
    Tung, Nadine
    Garber, Judy E.
    Lincoln, Anne
    Domchek, Susan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (35) : 4447 - 4448
  • [23] Survival outcomes for Indonesian women with locally advanced triple-negative breast cancer
    Khambri, D.
    Harahap, W. Arif
    BREAST, 2017, 32 : S66 - S66
  • [24] Survival outcomes and prognosis in patients with triple-negative breast cancer and brain metastases
    An, R.
    Wang, Y.
    Gao, C.
    Raghavendra, A. S.
    Amaya, D.
    Ibrahim, N.
    Li, J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S465 - S465
  • [25] Effect of incorporation of cisplatin to adjuvant chemotherapy for triple-negative breast cancer patients of unknown BRCA mutation status on survival.
    Hung, Chia-Yen
    Su, Ying-Wen
    Hsieh, Ruey Kuen
    Lam, Hung-Bun
    Chang, Yuan-Ching
    Yang, Po-Sheng
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Triple Negative Breast Cancer in BRCA1 Mutation Carriers With a Complete Radiologic Response to Neoadjuvant Paclitaxel: A Case Report
    Burness, Monika L.
    Obeid, Elias I.
    Olopade, Olufunmilayo I.
    CLINICAL BREAST CANCER, 2015, 15 (02) : E155 - E158
  • [27] Menopausal Status and Outcomes of BRCA Mutation Carriers with Breast Cancer
    Carlson, Kjirsten
    Chung, Alice
    Mirocha, James
    Donovan, Cory
    Estrada, Sylvia
    Siegel, Emily
    Giuliano, Armando
    Amersi, Farin
    AMERICAN SURGEON, 2018, 84 (10) : 1584 - 1588
  • [28] Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers
    Shani Paluch-Shimon
    Eitan Friedman
    Raanan Berger
    Moshe Papa
    Maya Dadiani
    Neil Friedman
    Moshe Shabtai
    Dov Zippel
    Mordechai Gutman
    Talia Golan
    Ady Yosepovich
    Raphael Catane
    Tami Modiano
    Bella Kaufman
    Breast Cancer Research and Treatment, 2016, 157 : 157 - 165
  • [29] Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers
    Paluch-Shimon, Shani
    Friedman, Eitan
    Berger, Raanan
    Papa, Moshe
    Dadiani, Maya
    Friedman, Neil
    Shabtai, Moshe
    Zippel, Dov
    Gutman, Mordechai
    Golan, Talia
    Yosepovich, Ady
    Catane, Raphael
    Modiano, Tami
    Kaufman, Bella
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (01) : 157 - 165
  • [30] Triple-Negative Breast Cancer: A Comparison of Race and Survival
    Doepker, Matthew P.
    Holt, Scott D.
    Durkin, Martin W.
    Chu, Christopher H.
    Nottingham, James M.
    AMERICAN SURGEON, 2018, 84 (06) : 881 - 888
12345